Evaluating the safety and efficacy of a novel treatment strategy in idiopathic inflammatory myopathies

Recruiting | Phase III | Autoimmune Disease | 18–75 years

Overview
This study evaluates the safety and efficacy of a novel treatment strategy in patients with moderate to severe idiopathic inflammatory myopathies.

Study population (general)
Adult patients with idiopathic inflammatory myopathies.

Principal Investigator
Assoc. Prof., MD Nguyễn Văn Đĩnh

Contact
CTU – Email – Phone

• Từ vựng
• Hán tự
• Dịch

Đang tìm kiếm …

Tiếng Anh

Cài đặt